Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study

British Medical Journal

Volumn 328, Issue 7445, 2004, Pages 931-

  'T Jong, Geert W ^a   Stricker, Bruno H Ch ^a   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ADVERTIZING; ARTICLE; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; DRUG MARKETING; HUMAN; MAJOR CLINICAL STUDY; ONYCHOMYCOSIS; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTIFUNGAL AGENTS; COHORT STUDIES; DRUG INDUSTRY; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MARKETING OF HEALTH SERVICES; MASS MEDIA; NAPHTHALENES; NETHERLANDS; ONYCHOMYCOSIS; PRESCRIPTIONS, DRUG;

EID: 1942446300     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Sheldon T. Dutch GPs call for ban on Novartis products. BMJ 2002;325:355.
2. Bräutigam M, Nolting S, Schopf RE, Weidinger G. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. BMJ 1995;311:919-22.
3. Nederlands Huisartsen Genootschap. Dermatomycosen (oktober 1997). http://nhg.artsennet.nl/upload/104/standaarden/M64/start.htm accessed 10 Feb 2004). (In Dutch.)
4. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999;38:339-44.